EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Reversion of heme-dependent metronidazole resistance in Clostridioides difficile

Lillia Louis iD, Firyal Ramzan iD, Dale D O Martin, Abiola O Olaitan iD

Microbiology Spectrum · 2026

DOI: 10.1128/spectrum.01787-25 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Microbiology Spectrum, 2026. Verfasst von Lillia Louis und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biology, University of Waterloo, Waterloo, Ontario, Canada. Hauptthemen laut MEDLINE: Metronidazole, Clostridioides difficile, Heme, Anti-Bacterial Agents. Die Arbeit nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Wellcome Trust.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Since the emergence of epidemic Clostridioides difficile in the early 2000s, reduced susceptibility to metronidazole (MTZ), once a frontline antibiotic for treating C. difficile infection, has emerged. Consequently, MTZ is no longer a guideline-recommended antibiotic in many countries. Heme and Nim proteins have been shown to co-mediate MTZ non-susceptibility by increasing the MTZ minimum inhibitory concentration (MIC). This study aimed to identify drugs that reverse heme-dependent MTZ non-susceptibility in C. difficile . Drugs known to interfere with heme were screened for their ability to inhibit MTZ non-susceptible C. difficile . Broth and agar dilution methods were used to assess the reversion of MTZ non-susceptibility in diverse clinical isolates, and checkerboard assay was used to determine drug-MTZ interactions. Gene expression analysis was performed using quantitative PCR and reporter assays. We uncovered artemisinin (ART) as an adjuvant capable of resensitizing heme-dependent MTZ non-susceptible C. difficile . ART reduced elevated MTZ MIC (1–8 µg/mL) in non-susceptible strains to the susceptible level (≤0.5 µg/mL) despite the presence of heme. Additionally, we demonstrated that ART reverses nim -mediated MTZ resistance in Bacteroides fragilis . The findings showed that ART significantly reduced intracellular hemin levels in C. difficile , even in the presence of exogenous hemin. This study identifies an adjuvant that repotentiates MTZ activity in non-susceptible C. difficile , where resistance is co-mediated by heme and the nim gene, offering a novel approach to restore MTZ susceptibility in anaerobes. IMPORTANCE Metronidazole (MTZ) is a widely used antibiotic for treating anaerobic bacterial infections, including Clostridioides difficile infection. However, the increasing emergence of MTZ resistance among anaerobic pathogens poses a significant threat to its continued clinical effectiveness. Heme-dependent MTZ resistance, one of the mechanisms of resistance, has been associated with poorer treatment outcomes in patients. In this study, we identified artemisinin (ART) and demonstrated that it can reverse heme-dependent MTZ resistance in diverse clinical isolates of C. difficile . Furthermore, ART effectively reversed resistance mediated by the nim genes in both C. difficile and Bacteroides fragilis . These findings open a possible avenue for restoring the efficacy of MTZ against resistant anaerobic bacteria, particularly those with the Nim-mediated resistance mechanism.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MetronidazoleClostridioides difficileHemeAnti-Bacterial AgentsDrug Resistance, BacterialMicrobial Sensitivity TestsHumansClostridium InfectionsBacterial ProteinsArtemisinins

Stichwörter der Autor:innen

5-nitroimidazole reductaseClostridium difficileantimicrobial resistancehememetronidazolenim genes

Substanzen

MetronidazoleHemeAnti-Bacterial AgentsartemisininBacterial ProteinsArtemisinins

Autor:innen und Institutionen

  • Department of Biology, University of Waterloo, Waterloo, Ontario, Canada.

ORCID-Profile: Lillia Louis, Firyal Ramzan, Abiola O Olaitan

Förderung

  • Wellcome Trust

Zitieren

APA

Louis, L., Ramzan, F., Martin, D. D., & Olaitan, A. O. (2026). Reversion of heme-dependent metronidazole resistance in Clostridioides difficile. Microbiology Spectrum. https://doi.org/10.1128/spectrum.01787-25

Vancouver

Louis L, Ramzan F, Martin DD, Olaitan AO. Reversion of heme-dependent metronidazole resistance in Clostridioides difficile. Microbiology Spectrum. 2026. doi:10.1128/spectrum.01787-25

BibTeX
@article{Louis2026,
  author = {Louis, Lillia and Ramzan, Firyal and Martin, Dale D O and Olaitan, Abiola O},
  title = {Reversion of heme-dependent metronidazole resistance in Clostridioides difficile},
  journal = {Microbiology Spectrum},
  year = {2026},
  doi = {10.1128/spectrum.01787-25}
}
Kostenlos starten →